All public logs
Jump to navigation
Jump to search
Combined display of all available logs of HemOnc.org - A Hematology Oncology Wiki. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)- 13:05, 23 September 2023 Warner-admin talk contribs moved page Category:Anti-CD33 BiTE antibodies to Category:Anti-CD33 bispecific T-cell engager antibodies without leaving a redirect (Text replacement - "BiTE antibodies" to "bispecific T-cell engager antibodies")
- 13:05, 23 September 2023 Warner-admin talk contribs moved page Category:Anti-GPRC5D BiTE antibodies to Category:Anti-GPRC5D bispecific T-cell engager antibodies without leaving a redirect (Text replacement - "BiTE antibodies" to "bispecific T-cell engager antibodies")
- 13:04, 23 September 2023 Warner-admin talk contribs moved page Category:Anti-CD19 BiTE antibodies to Category:Anti-CD19 bispecific T-cell engager antibodies without leaving a redirect (Text replacement - "BiTE antibodies" to "bispecific T-cell engager antibodies")
- 13:03, 23 September 2023 Warner-admin talk contribs moved page Category:BiTE antibodies to Category:Bispecific T-cell engager antibodies without leaving a redirect
- 12:16, 23 September 2023 Jwarner talk contribs created page Category:Synthetic muramyl dipeptides (Created page with "Category:Immunotherapeutic")
- 11:51, 23 September 2023 Jwarner talk contribs created page Category:GnRH analogs (Created page with "Category:Endocrine therapeutic")
- 11:27, 23 September 2023 Jwarner talk contribs created page Category:JAK3 inhibitors (Created page with "Category:JAK inhibitors")
- 11:25, 23 September 2023 Jwarner talk contribs created page Category:JAK1 inhibitors (Created page with "Category:JAK inhibitors")
- 11:24, 23 September 2023 Jwarner talk contribs created page Category:JAK2 inhibitors (Created page with "Category:JAK inhibitors")
- 00:29, 23 September 2023 Jwarner talk contribs created page Category:Anti-IL-2R immunotoxins (Created page with "Category:Immunotoxin")
- 00:12, 23 September 2023 Jwarner talk contribs created page Category:Topoisomerase II inhibitors (Created page with "Category:Topoisomerase inhibitors")
- 23:39, 22 September 2023 Warner-admin talk contribs deleted page Category:Cancer of unknown primary medications (content was: "Drugs that have some degree of efficacy in cancers of unknown primary site. Category:Site-agnostic medications", and the only contributor was "Jwarner" (talk))
- 23:39, 22 September 2023 Warner-admin talk contribs deleted page Category:Adenocarcinoma of unknown primary medications (content was: "Drugs with some demonstrated degree of efficacy in the treatment of adenocarcinoma of unknown primary. Category:Site-agnostic medications", and the only contributor was "Jwarner" (talk))
- 23:38, 22 September 2023 Warner-admin talk contribs deleted page Category:NTRK medications (content was: "Medications with some degree of efficacy in the treatment of NTRK-mutated tumors, regardless of anatomic site of origin. Category:Site-agnostic medications", and the only contributor was "Jwarner" (talk))
- 23:38, 22 September 2023 Jwarner talk contribs moved page Category:SMO or PTCH-1 (Hedgehog) medications to Category:Malignant solid neoplasm, SMO-mutated or PTCH-1-mutated (Hedgehog) medications
- 23:37, 22 September 2023 Jwarner talk contribs moved page SMO or PTCH-1 (Hedgehog) to Malignant solid neoplasm, SMO-mutated or PTCH-1-mutated (Hedgehog)
- 23:37, 22 September 2023 Jwarner talk contribs moved page Category:SMO or PTCH-1 (Hedgehog) regimens to Category:Malignant solid neoplasm, SMO-mutated or PTCH-1-mutated (Hedgehog) regimens
- 23:33, 22 September 2023 Jwarner talk contribs moved page Category:TMB-H medications to Category:Malignant solid neoplasm, TMB-H medications
- 23:32, 22 September 2023 Jwarner talk contribs moved page TMB-H to Malignant solid neoplasm, TMB-H
- 23:32, 22 September 2023 Jwarner talk contribs moved page Category:TMB-H regimens to Category:Malignant solid neoplasm, TMB-H regimens
- 23:31, 22 September 2023 Jwarner talk contribs moved page Category:RET medications to Category:Malignant solid neoplasm, RET-mutated medications
- 23:30, 22 September 2023 Jwarner talk contribs moved page RET to Malignant solid neoplasm, RET-mutated
- 23:29, 22 September 2023 Jwarner talk contribs moved page Category:RET regimens to Category:Malignant solid neoplasm, RET-mutated regimens
- 13:11, 22 September 2023 Warner-admin talk contribs created page File:Beau.jpeg
- 13:11, 22 September 2023 Warner-admin talk contribs uploaded File:Beau.jpeg
- 13:07, 22 September 2023 Warner-admin talk contribs created page File:Choe.jpeg
- 13:07, 22 September 2023 Warner-admin talk contribs uploaded File:Choe.jpeg
- 23:37, 21 September 2023 Jwarner talk contribs created page Category:Malignant solid neoplasm, NTRK-mutated medications (Created page with "Medications with some degree of efficacy in the treatment of NTRK-mutated solid tumors, regardless of anatomic site of origin. Ca...")
- 23:33, 21 September 2023 Jwarner talk contribs moved page Category:NTRK regimens to Category:Malignant solid neoplasm, NTRK-mutated regimens
- 23:32, 21 September 2023 Jwarner talk contribs moved page NTRK to Malignant solid neoplasm, NTRK-mutated
- 23:24, 21 September 2023 Jwarner talk contribs moved page Category:MSI-H or dMMR medications to Category:Malignant solid neoplasm, MSI-H or dMMR medications
- 23:23, 21 September 2023 Jwarner talk contribs moved page Category:MSI-H or dMMR regimens to Category:Malignant solid neoplasm, MSI-H or dMMR regimens
- 23:22, 21 September 2023 Jwarner talk contribs moved page MSI-H or dMMR to Malignant solid neoplasm, MSI-H or dMMR
- 21:48, 21 September 2023 Jwarner talk contribs moved page ERBB3 (HER3) to Malignant solid neoplasm, ERBB3-mutated
- 21:48, 21 September 2023 Jwarner talk contribs moved page Category:ERBB3 (HER3) regimens to Category:Malignant solid neoplasm, ERBB3-mutated regimens
- 21:07, 21 September 2023 Jwarner talk contribs moved page Category:ERBB3 (HER3) medications to Category:Malignant solid neoplasm, ERBB3-mutated medications
- 21:07, 21 September 2023 Jwarner talk contribs moved page Category:ERBB2 (HER2) medications to Category:Malignant solid neoplasm, ERBB2-mutated medications
- 21:05, 21 September 2023 Jwarner talk contribs moved page Category:ERBB2 (HER2) regimens to Category:Malignant solid neoplasm, ERBB2-mutated regimens
- 21:04, 21 September 2023 Jwarner talk contribs moved page ERBB2 (HER2) to Malignant solid neoplasm, ERBB2-mutated
- 16:29, 21 September 2023 Warner-admin talk contribs deleted page Solid malignant neoplasm, EGFR-mutated (content was: "#REDIRECT Malignant solid neoplasm, EGFR-mutated", and the only contributor was "Jwarner" (talk))
- 16:27, 21 September 2023 Jwarner talk contribs moved page Category:Solid malignant neoplasm, EGFR-mutated regimens to Category:Malignant solid neoplasm, EGFR-mutated regimens
- 16:27, 21 September 2023 Jwarner talk contribs moved page Solid malignant neoplasm, EGFR-mutated to Malignant solid neoplasm, EGFR-mutated
- 16:26, 21 September 2023 Jwarner talk contribs moved page Category:Solid malignant neoplasm, EGFR-mutated medications to Category:Malignant solid neoplasm, EGFR-mutated medications
- 16:07, 21 September 2023 Jwarner talk contribs moved page Category:EGFR medications to Category:Solid malignant neoplasm, EGFR-mutated medications
- 16:04, 21 September 2023 Jwarner talk contribs moved page Category:EGFR regimens to Category:Solid malignant neoplasm, EGFR-mutated regimens
- 16:03, 21 September 2023 Jwarner talk contribs moved page EGFR to Solid malignant neoplasm, EGFR-mutated
- 15:15, 21 September 2023 Jwarner talk contribs moved page Category:BRAF medications to Category:Malignant solid neoplasm, BRAF-mutated medications
- 15:13, 21 September 2023 Jwarner talk contribs moved page Category:BRAF regimens to Category:Malignant solid neoplasm, BRAF-mutated regimens
- 15:12, 21 September 2023 Jwarner talk contribs moved page BRAF to Malignant solid neoplasm, BRAF-mutated
- 16:04, 20 September 2023 User account Jonesef talk contribs was created